- 関
- noncompetitive inhibition
WordNet
- (physiology) the process whereby nerves can retard or prevent the functioning of an organ or part; "the inhibition of the heart by the vagus nerve"
- (psychology) the conscious exclusion of unacceptable thoughts or desires (同)suppression
- the quality of being inhibited
- not inclined to compete
PrepTutorEJDIC
- 禁止; 抑制; (心理学で)抑制; (化学で)(反応の)阻害, 抑制
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/12/01 20:37:48」(JST)
[Wiki en表示]
Not to be confused with Non-competitive inhibition.
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (August 2013) (Learn how and when to remove this template message) |
Uncompetitive inhibition, also known as anti-competitive inhibition, takes place when an enzyme inhibitor binds only to the complex formed between the enzyme and the substrate (the E-S complex).
While uncompetitive inhibition requires that an enzyme-substrate complex must be formed, non-competitive inhibition can occur with or without the substrate present.
Mechanism
This reduction in the effective concentration of the E-S complex increases the enzyme's apparent affinity for the substrate through Le Chatelier's principle (Km is lowered) and decreases the maximum enzyme activity (Vmax), as it takes longer for the substrate or product to leave the active site. Uncompetitive inhibition works best when substrate concentration is high. An uncompetitive inhibitor need not resemble the substrate of the reaction it is inhibiting.
Mathematical definition
Lineweaver–Burk plot of uncompetitive enzyme inhibition.
The Lineweaver–Burk equation states that:
Where v is the initial reaction velocity, Km is the Michaelis–Menten constant, Vmax is the maximum reaction velocity, and [S] is the concentration of the substrate.[1]
The Lineweaver–Burk plot for an uncompetitive inhibitor produces a line parallel to the original enzyme-substrate plot, but with a higher y-intercept, due to the presence of an inhibition term :
Where [I] is the concentration of the inhibitor and Ki is an inhibition constant characteristic of the inhibitor.[2][3]
Notes and references
- ^ Cleland, W. W. (1963). "The kinetics of enzyme-catalyzed reactions with two or more substrates or products". Biochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects. 67: 173–187. doi:10.1016/0926-6569(63)90226-8. PMID 14021668.
- ^ Rhodes, David. "Enzyme Kinetics - Single Substrate, Uncompetitive Inhibition, Lineweaver-Burk Plot". Purdue University. Retrieved 31 August 2013.
- ^ Cornish-Bowden, A. (1974). "A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors". The Biochemical Journal. 137 (1): 143–144. doi:10.1042/bj1370143. PMC 1166095. PMID 4206907.
Pharmacology: enzyme inhibition
|
|
Class |
- Competitive inhibition
- Uncompetitive inhibition
- Non-competitive inhibition
- Suicide inhibition
- Mixed inhibition
|
|
Substrate |
Oxidoreductase (EC 1) |
- 1.1 Aldose reductase
- HMG-CoA reductase
- 1.5 Dihydrofolate reductase
- 1.17 Xanthine oxidase
- Ribonucleotide reductase
|
|
Transferase (EC 2) |
- 2.1 COMT
- Thymidylate synthase
- 2.5 Dihydropteroate synthetase
- Farnesyltransferase
- 2.7 Nucleotidyltransferase
- Integrase
- Reverse transcriptase
- Protein kinase
|
|
Hydrolase (EC 3) |
- 3.1 Phosphodiesterase
- Acetylcholinesterase
- Ribonuclease
- 3.2 Polygalacturonase
- Neuraminidase
- Alpha-glucosidase
- 3.4 Protease: Exopeptidase
- Endopeptidase
- Mixed
- Enkephalinase
- Matrix metalloproteinase
- Oxytocinase
- 3.5 Histone deacetylase
- Beta-lactamase
|
|
Lyase (EC 4) |
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Thiol oxidation is crucial in the desensitization of the mitochondrial F1FO-ATPase to oligomycin and other macrolide antibiotics.
- Nesci S1, Ventrella V1, Trombetti F1, Pirini M1, Pagliarani A2.Author information 1Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064 Ozzano Emilia, Bologna, Italy.2Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064 Ozzano Emilia, Bologna, Italy. Electronic address: alessandra.pagliarani@unibo.it.AbstractBACKGROUND: The macrolide antibiotics oligomycin, venturicidin and bafilomycin, sharing the polyketide ring and differing in the deoxysugar moiety, are known to block the transmembrane ion channel of ion-pumping ATPases; oligomycins are selective inhibitors of mitochondrial ATP synthases.
- Biochimica et biophysica acta.Biochim Biophys Acta.2014 Jun;1840(6):1882-91. doi: 10.1016/j.bbagen.2014.01.008. Epub 2014 Jan 9.
- BACKGROUND: The macrolide antibiotics oligomycin, venturicidin and bafilomycin, sharing the polyketide ring and differing in the deoxysugar moiety, are known to block the transmembrane ion channel of ion-pumping ATPases; oligomycins are selective inhibitors of mitochondrial ATP synthases.METHODS: Th
- PMID 24412197
- Allantoinase and dihydroorotase binding and inhibition by flavonols and the substrates of cyclic amidohydrolases.
- Peng WF1, Huang CY2.Author information 1School of Biomedical Sciences, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd., Taichung City, Taiwan; School of Medicine, College of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd., Taichung City, Taiwan.2School of Biomedical Sciences, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd., Taichung City, Taiwan; Department of Medical Research, Chung Shan Medical University Hospital, No. 110, Sec. 1, Chien-Kuo N. Rd., Taichung City, Taiwan. Electronic address: cyhuang@csmu.edu.tw.AbstractAllantoinase and dihydroorotase are members of the cyclic amidohydrolases family. Allantoinase and dihydroorotase possess very similar binuclear metal centers in the active site and may use a similar mechanism for catalysis. However, whether the substrate specificities of allantoinase and dihydroorotase overlap and whether the substrates of other cyclic amidohydrolases inhibit allantoinase and dihydroorotase remain unknown. In this study, the binding and inhibition of allantoinase (Salmonella enterica serovar Typhimurium LT2) and dihydroorotase (Klebsiella pneumoniae) by flavonols and the substrates of other cyclic amidohydrolases were investigated. Hydantoin and phthalimide, substrates of hydantoinase and imidase, were not hydrolyzed by allantoinase and dihydroorotase. Hydantoin and dihydroorotate competitively inhibited allantoinase, whereas hydantoin and allantoin bind to dihydroorotase, but do not affect its activity. We further investigated the effects of the flavonols myricetin, quercetin, kaempferol, and galangin, on the inhibition of allantoinase and dihydroorotase. Allantoinase and dihydroorotase were both significantly inhibited by kaempferol, with IC50 values of 35 ± 3 μM and 31 ± 2 μM, respectively. Myricetin strongly inhibited dihydroorotase, with an IC50 of 40 ± 1 μM. The double reciprocal of the Lineweaver-Burk plot indicated that kaempferol was a competitive inhibitor for allantoinase but an uncompetitive inhibitor for dihydroorotase. A structural study using PatchDock showed that kaempferol was docked in the active site pocket of allantoinase but outside the active site pocket of dihydroorotase. These results constituted a first study that naturally occurring product flavonols inhibit the cyclic amidohydrolases, allantoinase, and dihydroorotase, even more than the substrate analogs (>3 orders of magnitude). Thus, flavonols may serve as drug leads for designing compounds that target several cyclic amidohydrolases.
- Biochimie.Biochimie.2014 Jun;101:113-22. doi: 10.1016/j.biochi.2014.01.001. Epub 2014 Jan 10.
- Allantoinase and dihydroorotase are members of the cyclic amidohydrolases family. Allantoinase and dihydroorotase possess very similar binuclear metal centers in the active site and may use a similar mechanism for catalysis. However, whether the substrate specificities of allantoinase and dihydrooro
- PMID 24418229
- Characterization of a thermostable 2,4-diaminopentanoate dehydrogenase from Fervidobacterium nodosum Rt17-B1.
- Fukuyama S1, Mihara H1, Miyake R2, Ueda M2, Esaki N1, Kurihara T3.Author information 1Institute for Chemical Research, Kyoto University, Gokasho, Uji, Kyoto 611-0011, Japan.2Mitsubishi Chemical Group Science and Technology Research Center, Inc., Yokohama 227-8502, Japan; API Corporation, Yokohama 227-8502, Japan.3Institute for Chemical Research, Kyoto University, Gokasho, Uji, Kyoto 611-0011, Japan. Electronic address: kurihara@scl.kyoto-u.ac.jp.Abstract2,4-Diaminopentanoate dehydrogenase (2,4-DAPDH), which is involved in the oxidative ornithine degradation pathway, catalyzes the NAD(+)- or NADP(+)-dependent oxidative deamination of (2R,4S)-2,4-diaminopentanoate (2,4-DAP) to form 2-amino-4-oxopentanoate. A Fervidobacterium nodosum Rt17-B1 gene, Fnod_1646, which codes for a protein with sequence similarity to 2,4-DAPDH discovered in metagenomic DNA, was cloned and overexpressed in Escherichia coli, and the gene product was purified and characterized. The purified protein catalyzed the reduction of NAD(+) and NADP(+) in the presence of 2,4-DAP, indicating that the protein is a 2,4-DAPDH. The optimal pH and temperature were 9.5 and 85°C, respectively, and the half-denaturation time at 90°C was 38 min. Therefore, the 2,4-DAPDH from F. nodosum Rt17-B1 is an NAD(P)(+)-dependent thermophilic-alkaline amino acid dehydrogenase. This is the first thermophilic 2,4-DAPDH reported, and it is expected to be useful for structural and functional analyses of 2,4-DAPDH and for the enzymatic production of chiral amine compounds. Activity of 2,4-DAPDH from F. nodosum Rt17-B1 was suppressed by 2,4-DAP via uncompetitive substrate inhibition. In contrast, the enzyme showed typical Michaelis-Menten kinetics toward 2,5-diaminohexanoate. The enzyme was uncompetitively inhibited by d-ornithine with an apparent Ki value of 0.1 mM. These results suggest a regulatory role for this enzyme in the oxidative ornithine degradation pathway.
- Journal of bioscience and bioengineering.J Biosci Bioeng.2014 May;117(5):551-6. doi: 10.1016/j.jbiosc.2013.11.002. Epub 2013 Dec 8.
- 2,4-Diaminopentanoate dehydrogenase (2,4-DAPDH), which is involved in the oxidative ornithine degradation pathway, catalyzes the NAD(+)- or NADP(+)-dependent oxidative deamination of (2R,4S)-2,4-diaminopentanoate (2,4-DAP) to form 2-amino-4-oxopentanoate. A Fervidobacterium nodosum Rt17-B1 gene, Fno
- PMID 24326351
Japanese Journal
- Synthesis and the Intestinal Glucosidase Inhibitory Activity of 2-Aminoresorcinol Derivatives toward an Investigation of Its Binding Site
- KATO Eisuke,OIKAWA Kenichi,TAKAHASHI Keisuke [他]
- Bioscience, Biotechnology, and Biochemistry 76(5), 1044-1046, 2012-05
- NAID 40019292878
- Inhibition of Aldose Reductase by Phenylethanoid Glycoside Isolated from the Seeds of Paulownia coreana
- Kim Jin Kyu,Lee Yeon Sil,Kim Seon Ha,Bae Young Soo,Lim Soon Sung
- Biological & Pharmaceutical Bulletin 34(1), 160-163, 2011
- … In kinetic analyses performed using Lineweaver–Burk plots of 1/velocity and 1/concentration of substrate, isocampneoside II (3) showed uncompetitive inhibition against rhAR. …
- NAID 130000402282
★リンクテーブル★
[★]
- 英
- noncompetitive inhibition、uncompetitive inhibition
- 関
- 不競合阻害、非競合的阻害、非競合的拮抗、非競合的抑制
[★]
- 英
- [[]]
- 同
- uncompetitive inhibition
- 関
- [[]]
- 同
- uncompetitive inhibition
[★]
- 英
- uncompetitive inhibition
- 関
- 非拮抗的阻害
[★]
- 1.抑止、抑制、阻止、禁止
- 2.抑止(阻止)するもの
- 3.(心理学)(衝動などの)抑制
- 4.(化)(化学反応の)抑制
- 5.(生物)(酵素の働きなどの)抑制、阻害
[★]
- 関
- uncompetitively